Ultima-Mots C 10mg

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: 125 rRNA-C, MIT-RNRI

Pack: 1 vial (10 mg)

Ultima-Mots C is a peptide composed of 16 amino acids that is produced by a mitochondrial gene. Research indicates that mitochondria are crucial for cellular signaling and energy production.

 

Ultima-Mots C influences metabolic processes throughout the body, particularly in converting glucose into usable energy. Initial studies suggest it may enhance blood sugar control in individuals with type 2 diabetes and obesity.

 

Research also demonstrates that skeletal muscle serves as the primary target tissue for Ultima-Mots C. This peptide boosts insulin sensitivity and promotes glucose absorption in myocytes (muscle cells) by activating the AMPK pathway without increasing insulin levels. Thus, Ultima-Mots C can be considered an exercise-mimetic, as it simulates the effects of exercise in the body. Similarly, exercise also enhances muscle glucose uptake without the need for insulin stimulation.

 

AMPK (AMP-activated protein kinase) was recognized in 1999 as the central regulator of metabolism, overseeing both glucose and lipid (fat) metabolism. Since then, it has become a focal point for therapeutic strategies aimed at addressing metabolic disorders such as type 2 diabetes.